Opportunity Information: Apply for RFA HD 18 034
The funding opportunity titled "Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)" was an NIH small business grant solicitation intended to support research and development of multipurpose prevention technologies (often referred to as MPTs). In practical terms, these are products or approaches designed to address more than one sexual and reproductive health need at the same time, with this particular call focusing on preventing HIV and preventing unintended pregnancy. The mechanism listed, R41/R42, indicates the NIH Small Business Innovation Research (SBIR) phased structure, where R41 generally aligns with early-stage feasibility work (Phase I) and R42 aligns with more advanced development activities (Phase II), typically moving an idea from proof-of-concept toward a more mature prototype or validated technology.
Administratively, this specific announcement (Funding Opportunity Number RFA HD 18 034) was categorized as a discretionary grant under the Health, Income Security and Social Services activity category, and it was associated with CFDA number 93.865. The sponsoring agency was the National Institutes of Health. The eligible applicant type was small businesses, reflecting that the opportunity was structured for U.S. small business concerns rather than universities or large nonprofits as primary applicants. While the listing references an original closing date of 2017-11-07 and a creation date of 2017-11-06, the central detail that governs its status is that the announcement was released early in error, was closed, and was explicitly slated to be reissued later under a different funding opportunity announcement number. In other words, even though the opportunity appeared briefly with an application deadline, NIH closed it and indicated that applicants should watch for a replacement solicitation rather than attempt to apply under this one.
On eligibility and foreign involvement, the notice is clear that non-domestic (non-U.S.) entities (foreign institutions) were not eligible to apply as applicants, and non-domestic components of U.S. organizations were also not eligible to apply. That said, the notice leaves room for "foreign components" as defined by the NIH Grants Policy Statement to be allowed. This distinction matters because it means the applicant organization had to be an eligible U.S. small business, but certain project elements might have been permitted to occur outside the United States if they met NIH policy definitions and were appropriately justified and approved. The key takeaway is that the applicant itself could not be a foreign institution, and a U.S. organization could not apply through an ineligible non-U.S. component, but limited foreign collaboration or performance sites might still have been possible under NIH rules.
Several standard fields in the source data, such as award ceiling and expected awards, are left blank, suggesting that the public-facing record did not specify a maximum award amount or the anticipated number of awards at the time of posting (or that these details were not captured in the summary record). Overall, the opportunity represents an NIH SBIR initiative aimed at accelerating innovation in combined HIV prevention and contraception technologies, but this particular posting should be treated as inactive because it was issued prematurely, formally closed, and intended to be replaced with a new announcement number at a later date.Apply for RFA HD 18 034
- The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
- This funding opportunity was created on 2017-11-06.
- Applicants must submit their applications by 2017-11-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
What is the title of this funding opportunity?
The funding opportunity is titled "Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)."
What is the main purpose of this grant solicitation?
The purpose is to support research and development of multipurpose prevention technologies (MPTs) designed to address more than one sexual and reproductive health need at the same time, with this call specifically focused on preventing HIV and preventing unintended pregnancy.
What are multipurpose prevention technologies (MPTs) in the context of this opportunity?
In this context, MPTs are products or approaches intended to provide combined protection, specifically targeting both HIV prevention and prevention of unintended pregnancy within a single technology or strategy.
Which agency sponsored this opportunity?
The sponsoring agency was the National Institutes of Health (NIH).
What funding mechanism does R41/R42 refer to?
R41/R42 refers to the NIH Small Business Innovation Research (SBIR) phased structure. R41 generally aligns with Phase I (early-stage feasibility work), and R42 generally aligns with Phase II (more advanced development activities), typically moving a project from proof-of-concept toward a more mature prototype or validated technology.
Is this opportunity part of the NIH SBIR program?
Yes. The R41/R42 mechanism indicates it was an NIH SBIR solicitation intended for eligible U.S. small business concerns.
Who was eligible to apply?
The eligible applicant type listed was small businesses. The opportunity was structured for U.S. small business concerns rather than universities or large nonprofits as primary applicants.
Are foreign (non-U.S.) institutions eligible to apply as applicants?
No. Non-domestic (non-U.S.) entities (foreign institutions) were not eligible to apply as applicants under this notice.
Can a U.S. organization apply through a non-U.S. component?
No. Non-domestic components of U.S. organizations were also not eligible to apply under this solicitation.
Does the notice allow any foreign involvement at all?
Yes, potentially. While foreign institutions could not be the applicant (and non-U.S. components of U.S. organizations were not eligible), the notice indicates that "foreign components" (as defined by the NIH Grants Policy Statement) could be allowed. This suggests the applicant had to be an eligible U.S. small business, but certain project elements might have been permitted to occur outside the United States if they met NIH policy definitions and were appropriately justified and approved.
What is the Funding Opportunity Number (FOA number) for this posting?
The Funding Opportunity Number listed was RFA HD 18 034.
What is the CFDA number associated with this opportunity?
The CFDA number associated with this opportunity was 93.865.
How was this opportunity categorized administratively?
It was categorized as a discretionary grant under the Health, Income Security and Social Services activity category.
What was the original closing date shown for this opportunity?
The listing references an original closing date of 2017-11-07.
What was the creation date shown in the listing?
The listing references a creation date of 2017-11-06.
Is this funding opportunity currently active and accepting applications?
No. The announcement was released early in error, was closed, and was explicitly slated to be reissued later under a different funding opportunity announcement number.
Should applicants apply under this FOA number (RFA HD 18 034)?
No. Based on the notice, applicants were expected to watch for a replacement solicitation (a reissued announcement under a different FOA number) rather than attempt to apply under this one.
Will this opportunity be reissued?
Yes. The notice states it was closed and intended to be reissued later under a different funding opportunity announcement number.
Does the public summary specify an award ceiling (maximum award amount)?
No. Standard fields such as award ceiling were left blank in the source data, indicating the public-facing record did not specify a maximum award amount (or that the detail was not captured in the summary record).
Does the public summary specify the expected number of awards?
No. The expected number of awards field was also left blank, suggesting the anticipated number of awards was not specified in the posted summary (or was not captured there).
What stage of development was NIH trying to support with this solicitation?
The use of the SBIR phased R41/R42 structure indicates NIH intended to support both early feasibility work (Phase I) and more advanced development (Phase II), moving concepts from proof-of-concept toward more mature prototypes or validated technologies.
What is the key status takeaway for someone evaluating this posting?
The key takeaway is that this specific posting should be treated as inactive: it was issued prematurely, formally closed, and intended to be replaced by a new announcement number.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: Surgical Disparities Research (R01 Clinical Trial Optional)
Previous opportunity: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 18 034
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 18 034) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional) Apply for PAR 18 095 Funding Number: PAR 18 095 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) Apply for RFA HD 18 033 Funding Number: RFA HD 18 033 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Contraception Research Centers Program (U54) Apply for RFA HD 18 035 Funding Number: RFA HD 18 035 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Trophoblast Differentiation and Function (R21 Clinical Trial Optional) Apply for PA 18 047 Funding Number: PA 18 047 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional) Apply for PA 18 048 Funding Number: PA 18 048 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21 Clinical Trial Optional) Apply for PA 18 093 Funding Number: PA 18 093 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 18 211 Funding Number: PAR 18 211 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $100,000 |
| Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) Apply for PAR 18 213 Funding Number: PAR 18 213 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) Apply for RFA HD 18 102 Funding Number: RFA HD 18 102 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42) Apply for RFA HD 18 101 Funding Number: RFA HD 18 101 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional) Apply for PAR 18 214 Funding Number: PAR 18 214 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Apply for PAR 18 215 Funding Number: PAR 18 215 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| NICHD Research Education Programs (R25 Clinical Trial Optional) Apply for PAR 18 217 Funding Number: PAR 18 217 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $150,000 |
| NICHD Small Grant Program (R03 - Clinical Trial Optional) Apply for PA 18 481 Funding Number: PA 18 481 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| NICHD Research Project Grant (R01 - Clinical Trial Required) Apply for PA 18 480 Funding Number: PA 18 480 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional) Apply for PA 18 482 Funding Number: PA 18 482 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R01 - Clinical Trial Optional) Apply for RFA HD 19 013 Funding Number: RFA HD 19 013 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional) Apply for PA 18 485 Funding Number: PA 18 485 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional) Apply for PA 18 491 Funding Number: PA 18 491 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 - Clinical Trial Optional) Apply for RFA HD 19 006 Funding Number: RFA HD 19 006 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 18 034", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.